SCHEDULE: PolyPid Ltd. Ownership Update: Key Investors Maintain Stake

An amended Schedule 13G filing reveals that Rodney Hodges and associated entities collectively hold a substantial 13.4% stake in PolyPid Ltd., including exercisable warrants.

Summary

• This filing is an amendment to a Schedule 13G, reporting changes in beneficial ownership of PolyPid Ltd. ordinary shares.
• Rodney Hodges, along with Geneva Holding Company (GHC) SA, Geneva Trust Company (GTC) SA, Centaurus Investments Limited, and Xenia Venture Capital Limited, are the reporting persons.
• Collectively, these reporting persons beneficially own 2,722,707 ordinary shares, representing 13.4% of the class of securities.
• This ownership includes warrants held by Xenia Venture Capital Limited and Oriella Limited, exercisable within 60 days of August 13, 2026.
• The percentage ownership is based on 20,311,766 ordinary shares outstanding as of June 30, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, reflecting a significant but stable ownership stake by key investment entities. The disclosure indicates continued strategic interest without immediate aggressive action.

Positives

• Significant collective ownership stake of 13.4% by reporting persons indicates strong investor confidence.
• The inclusion of exercisable warrants suggests potential for increased future ownership and strategic involvement.
• The filing is an amendment, indicating ongoing management and reporting by these significant investors.

Negatives

• No new capital is being injected or raised in this filing.
• The filing does not detail any new strategic initiatives or operational improvements by the company itself.

Risks

• The beneficial ownership includes warrants that are exercisable within 60 days of August 13, 2026, which could lead to increased share dilution or changes in ownership structure.
• The concentration of ownership among a few entities could potentially influence control dynamics of the issuer.

Future Outlook

The filing notes that warrants held by Xenia Venture Capital Limited and Oriella Limited are exercisable within 60 days of August 13, 2026, which could impact future share counts and ownership percentages.

Management Comments

• Rodney Hodges disclaims beneficial ownership of the Ordinary Shares held by the Reporting Entities except to the extent of his pecuniary interest therein, as he does not make day-to-day voting or investment decisions.
• The reporting persons certify that the securities were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders to report their stakes. The continued reporting by these entities suggests ongoing strategic interest in the biotechnology or pharmaceutical sector, where PolyPid Ltd. operates.

Stakeholder Impact

• Shareholders: The continued significant stake and potential exercise of warrants by these entities may influence share price and future corporate actions.
• Management: The reporting persons' substantial ownership and disclaimers on control influence may impact strategic discussions and board representation.

Next Steps

• The reporting persons may exercise their warrants within 60 days of August 13, 2026.
• Future amendments to Schedule 13G may be filed if there are further changes in beneficial ownership.

Key Dates

Keywords

PolyPid Ltd., Schedule 13G, Beneficial Ownership, Ordinary Shares, Warrants, Rodney Hodges, Xenia Venture Capital, Centaurus Investments